Clinical trials: Gynecologycal Cancer
Endometrial Cancer, Recurrent Endometrial Carcinoma
First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without Nesuparib, in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient (pMMR) Endometrial Cancer
The goal of this study is listed below. Part A (Safety Run-in Phase) : To determine feasibility of pembrolizumab and nesuparib combination as maintenance therapy in patients with MMR-proficient advanced and recurrent endometrial…
- Conditions
- Endometrial Cancer, Recurrent Endometrial Carcinoma, Endometrial Carcinoma, Gynecologycal Cancer
- Trial name
- PENELOPE (NCT06502743)
- Testing
- Nesuparib, Pembrolizumab
- Where
- 6 sites in South Korea
- Volunteers
- 92 people
- Sponsor
- Yonsei University
Gynecologycal Cancer
Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer
The purpose of this research study is to see if patients with endometrial and ovarian cancer are willing to complete physical and cognitive assessments before treatment and again after treatment has ended.
- Trial name
- MITO-RES (NCT07046936)
- Testing
- muscle sample, blood draw
- Where
- 2 sites in United States
- Volunteers
- 30 people
- Sponsor
- Wake Forest University Health Sciences
Gynecologycal Cancer, Cancer Related Pain
The Effectiveness of Battlefield Acupuncture (BFA) With Standard Therapy in Gynecological Cancer Pain
Pain is one of the most important symptoms of cancer patients, with nearly 40% of all cancer patients experiencing moderate to severe pain.
- Conditions
- Gynecologycal Cancer, Cancer Related Pain, Cancer Pain
- Trial name
- NCT06115330
- Testing
- Press Needle Acupuncture
- Where
- 3 sites in Indonesia
- Volunteers
- 58 people
- Sponsor
- Universitas Indonesia